Schroder Investment Management Group’s Disc Medicine IRON Stock Holding History

Schroder Investment Management Group’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.73M	Sell	50,000 -959	-2%	-$65.9K	﹤0.01%	825
2026 Q1	$3.1M	Buy	50,959 +856	+2%	+$59.4K	﹤0.01%	855
2025 Q4	$3.85M	Sell	50,103 -17,093	-25%	-$1.44M	﹤0.01%	800
2025 Q3	$4.37M	Sell	67,196 -15,255	-19%	-$907K	﹤0.01%	794
2025 Q2	$4.49M	Sell	82,451 -4,839	-6%	-$227K	﹤0.01%	783
2025 Q1	$4.57M	Sell	87,290 -4,200	-5%	-$234K	﹤0.01%	771
2024 Q4	$5.64M	Sell	91,490 -1,089	-1%	-$63K	0.01%	752
2024 Q3	$4.64M	Buy	92,579 +440	+0.5%	+$20.7K	﹤0.01%	797
2024 Q2	$4.15M	Buy	92,139 +35,663	+63%	+$1.21M	﹤0.01%	811
2024 Q1	$3.52M	Sell	56,476 -1,784	-3%	-$116K	﹤0.01%	841
2023 Q4	$3.37M	Buy	+58,260	New	+$2.98M	﹤0.01%	833

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Schroder Investment Management Group's IRON Position: Q2 2026 in Review

Schroder Investment Management Group reduced its Disc Medicine (IRON) stake by 1.9% in Q2 2026, selling an estimated $65.9K and leaving 50,000 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #825.

Schroder Investment Management Group first reported a position in IRON in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.64M in Q4 2024. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Schroder Investment Management Group held 50,000 shares of Disc Medicine worth $3.73M as of Q2 2026.
Schroder Investment Management Group sold 959 Disc Medicine shares in Q2 2026, an estimated $65.9K.
Disc Medicine made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #825 holding.
Schroder Investment Management Group first reported a position in Disc Medicine in Q4 2023 and has held it in 11 quarters since.
Schroder Investment Management Group's Disc Medicine position peaked at $5.64M in Q4 2024.
215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.